Remove Clinical Trials Remove Conditions Remove Magazine
article thumbnail

Let’s Explore These Therapeutic Drugs That Were Accidental Discoveries

Veriheal

Discover Magazine described the first antidepressant, iproniazid, as a “psychic energizer”. MAOIs are important for inhibiting neurotransmitters that have been impacted by depression, thus allowing some relief from the condition. Iproniazid – The First MOAI Antidepressant. Isn’t it funny how life works?

article thumbnail

Israel’s Tikun Olam Making Moves in the U.S. and Canada

Freedom Leaf

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

article thumbnail

3 Ways Florida Medical Marijuana Can Be Used to Fight Cancer

FloridaMarijuana.net

Newsweek Magazine labeled marijuana the “wonder drug when it comes to the horrors of chemo.” The American Cancer Society reported that studies have consistently shown that during clinical trials patients who used marijuana extracts needed less pain medicine and opioids.

article thumbnail

Does CBD Work for Pain Relief?

NewsMunchies

It is a way of life for those suffering with debilitating medical conditions that bring about widespread body aches, joint pain, and muscle tension. CBD, short for cannabidiol, claims to treat a variety of conditions including pain, anxiety, and insomnia, just to name a few. Chronic pain represents an emerging public health issue.

CBD 98
article thumbnail

July 18: Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review

Cannabis Law Report

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. Yensen has admitted to having sex with Buisson after the experimental sessions ended, but while she was still enrolled in the clinical trial.

Safety 52
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.